slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
11.020
KRW
|
-2,65%
|
|
+1,47%
|
+20,31%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
70.067
|
76.165
|
123.061
|
93.238
|
88.582
|
101.553
|
Bedrijfswaarde
1 |
48.995
|
52.328
|
58.516
|
40.899
|
24.595
|
59.819
|
K/w-verhouding
|
11,3
x
|
13,3
x
|
21,1
x
|
13,6
x
|
10,1
x
|
24
x
|
Dividendrendement
|
0,79%
|
0,73%
|
0,45%
|
0,59%
|
0,63%
|
0,55%
|
Marktkapitalisatie/omzet
|
0,98
x
|
1,1
x
|
1,61
x
|
1,12
x
|
0,95
x
|
1,16
x
|
Bedrijfswaarde/omzet
|
0,68
x
|
0,75
x
|
0,77
x
|
0,49
x
|
0,26
x
|
0,68
x
|
Bedrijfswaarde/EBITDA
|
5,07
x
|
5,4
x
|
5,46
x
|
3,24
x
|
2,18
x
|
8,31
x
|
Bedrijfswaarde/FCF
|
18,2
x
|
-13,3
x
|
7,76
x
|
-122
x
|
-13,8
x
|
-12,9
x
|
FCF Yield
|
5,5%
|
-7,53%
|
12,9%
|
-0,82%
|
-7,25%
|
-7,77%
|
Price to Book
|
0,94
x
|
0,94
x
|
1,18
x
|
0,84
x
|
0,75
x
|
0,83
x
|
Aantal aandelen (in duizenden)
|
11.087
|
11.087
|
11.087
|
11.087
|
11.087
|
11.087
|
Referentieprijs
2 |
6.320
|
6.870
|
11.100
|
8.410
|
7.990
|
9.160
|
Datum van publicatie
|
21-03-19
|
18-03-20
|
22-03-21
|
21-03-22
|
21-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
71.823
|
69.537
|
76.255
|
82.957
|
93.504
|
87.622
|
EBITDA
1 |
9.666
|
9.689
|
10.717
|
12.623
|
11.289
|
7.199
|
Bedrijfsresultaat (EBIT)
1 |
7.923
|
7.352
|
8.122
|
9.685
|
8.174
|
3.801
|
Operationele Marge
|
11,03%
|
10,57%
|
10,65%
|
11,68%
|
8,74%
|
4,34%
|
Resultaat voor belastingen (EBT)
1 |
8.046
|
7.733
|
8.679
|
12.195
|
10.713
|
6.305
|
Nettowinst (verlies)
1 |
6.223
|
5.727
|
5.821
|
6.789
|
8.628
|
4.182
|
Nettomarge
|
8,66%
|
8,24%
|
7,63%
|
8,18%
|
9,23%
|
4,77%
|
WPA
2 |
561,3
|
516,5
|
526,0
|
619,0
|
788,0
|
382,0
|
Free Cash Flow
1 |
2.696
|
-3.940
|
7.538
|
-335,4
|
-1.784
|
-4.645
|
FCF-marge
|
3,75%
|
-5,67%
|
9,89%
|
-0,4%
|
-1,91%
|
-5,3%
|
Kasstroomconversie (ebitda)
|
27,89%
|
-
|
70,34%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
43,32%
|
-
|
129,5%
|
-
|
-
|
-
|
Dividend per aandeel
2 |
50,00
|
50,00
|
50,00
|
50,00
|
50,00
|
50,00
|
Datum van publicatie
|
21-03-19
|
18-03-20
|
22-03-21
|
21-03-22
|
21-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
21.072
|
23.837
|
64.545
|
52.339
|
63.987
|
41.734
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.696
|
-3.940
|
7.538
|
-335
|
-1.784
|
-4.645
|
ROE (netto-inkomsten/eigen vermogen)
|
9,02%
|
7,75%
|
6,93%
|
7,55%
|
8,25%
|
4,1%
|
ROA (netto-inkomsten/totale activa)
|
5,92%
|
4,86%
|
4,03%
|
3,87%
|
2,92%
|
1,25%
|
Totale activa
1 |
105.173
|
117.806
|
144.433
|
175.531
|
295.003
|
335.459
|
Nettoactief per aandeel
2 |
6.731
|
7.289
|
9.423
|
9.993
|
10.701
|
11.027
|
Cashflow per aandeel
2 |
836,0
|
1.057
|
909,0
|
560,0
|
655,0
|
1.295
|
Capex
1 |
3.596
|
7.163
|
8.570
|
6.321
|
5.532
|
9.422
|
Capex/omzet
|
5,01%
|
10,3%
|
11,24%
|
7,62%
|
5,92%
|
10,75%
|
Datum van publicatie
|
21-03-19
|
18-03-20
|
22-03-21
|
21-03-22
|
21-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +20,31% | 88,34 mln. | | +40,73% | 739 mld. | | +32,83% | 598 mld. | | -6,42% | 353 mld. | | +15,15% | 318 mld. | | +4,05% | 285 mld. | | +15,00% | 240 mld. | | -5,52% | 206 mld. | | +6,19% | 164 mld. | | -0,45% | 162 mld. |
Farmaceutische producten - Andere
|